231 filings
Page 5 of 12
424B5
2j8cn5wiprqz
28 Oct 20
Prospectus supplement for primary offering
4:32pm
8-K
dlezt39l5oaw104t612
9 Sep 20
Forte Biosciences, Inc. Announces Full Publication of Phase 1/2 Data In Science Translational Medicine
4:06pm
424B5
ez2kvn2zl8n7y
4 Sep 20
Prospectus supplement for primary offering
4:51pm
8-K
ju55m8roagzmbz2wh 56
4 Sep 20
Audited Financial Statements
4:31pm
S-8
ilk yvvkusj
11 Aug 20
Registration of securities for employees
5:19pm
8-K
8z6c5 pea
10 Aug 20
Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
4:04pm
8-K/A
9watlizh98p4l4 bewo
10 Aug 20
Financial Statements and Exhibits
4:02pm
8-K
u0278
21 Jul 20
Changes in Registrant's Certifying Accountant
4:34pm
8-K
21ly0tfoxtt7yav4vmn
26 Jun 20
Regulation FD Disclosure
5:09pm
8-K
geqay0t4g
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
8-K
ipd6a2eb9g1wdrhg
12 Jun 20
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
83u4 oxwaj
8 Jun 20
Other Events
5:25pm
DEFA14A
nsp03e6
28 May 20
Additional proxy soliciting materials
4:57pm
EFFECT
mnu23g6hlgu
14 May 20
Notice of effectiveness
12:15am
424B3
h1umgjv6kp1 u30dh
14 May 20
Prospectus supplement
12:00am
CORRESP
wikc4ot
13 May 20
Correspondence with SEC
12:00am
CORRESP
f5qb7h9z2iz3d6i496fc
12 May 20
Correspondence with SEC
12:00am